Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 17 May 1991:
Vol. 252. no. 5008, pp. 961 - 965
DOI: 10.1126/science.2035026
Prev | Table of Contents | Next

Articles

Science, Vol 252, Issue 5008, 961-965
Copyright © 1991 by American Association for the Advancement of Science

articles

LAV revisited: origins of the early HIV-1 isolates from Institut Pasteur

S Wain-Hobson, JP Vartanian, M Henry, N Chenciner, R Cheynier, S Delassus, LP Martins, M Sala, MT Nugeyre, D Guetard, and al. et

Laboratoire de Retrovirologie Moleculaire, Institut Pasteur, Paris.

Two of the first human immunodeficiency virus type-1 (HIV-1) strains isolated were authenticated by reanalyzing original cultured samples stored at the Collection Nationale de Culture des Microorganismes as well as uncultured primary material. Cloned polymerase chain reaction products were used to analyze coding sequences of the V3 loop in the gp120 glycoprotein. The original isolate HIV-1 Bru, formerly called LAV, was derived from patient BRU. HIV-1 Lai was derived from patient LAI and contaminated a HIV-1 Bru culture between 20 July and 3 August 1983. The culture became, in effect, HIV-1 Lai, identifiable by a unique motif in the V3 loop. Because of this contamination two, rather than one, HIV-1 isolates were sent to the Laboratory of Tumor Cell Biology at the National Cancer Institute on 23 September 1983. Original HIV-1 Bru was indeed present in the sample marked JBB/LAV. However the M2T-/B sample harbored HIV-1 Lai, a strain capable of growing on established cell lines. The striking similarity between HIV-1 Lai (formerly LAV-Bru) and HTLV-3B sequences remains.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Dynamic Host Energetics and Cytoskeletal Proteomes in Human Immunodeficiency Virus Type 1-Infected Human Primary CD4 Cells: Analysis by Multiplexed Label-Free Mass Spectrometry.
E. Y. Chan, J. N. Sutton, J. M. Jacobs, A. Bondarenko, R. D. Smith, and M. G. Katze (2009)
J. Virol. 83, 9283-9295
   Abstract »    Full Text »    PDF »
CCL2 Increases X4-tropic HIV-1 Entry into Resting CD4+ T Cells.
G. R. Campbell and S. A. Spector (2008)
J. Biol. Chem. 283, 30745-30753
   Abstract »    Full Text »    PDF »
Phylogenetic Evidence against Evolutionary Stasis and Natural Abiotic Reservoirs of Influenza A Virus.
M. Worobey (2008)
J. Virol. 82, 3769-3774
   Abstract »    Full Text »    PDF »
Quantitative Analysis of Human Immunodeficiency Virus Type 1-Infected CD4+ Cell Proteome: Dysregulated Cell Cycle Progression and Nuclear Transport Coincide with Robust Virus Production.
E. Y. Chan, W.-J. Qian, D. L. Diamond, T. Liu, M. A. Gritsenko, M. E. Monroe, D. G. Camp II, R. D. Smith, and M. G. Katze (2007)
J. Virol. 81, 7571-7583
   Abstract »    Full Text »    PDF »
HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes.
M. M. Goodenow and R. G. Collman (2006)
J. Leukoc. Biol. 80, 965-972
   Abstract »    Full Text »    PDF »
Human immunodeficiency virus type 1 (HIV-1) induces activation of multiple STATs in CD4+ cells of lymphocyte or monocyte/macrophage lineages.
J. J. Kohler, D. L. Tuttle, C. R. Coberley, J. W. Sleasman, and M. M. Goodenow (2003)
J. Leukoc. Biol. 73, 407-416
   Abstract »    Full Text »    PDF »
The Maturation of Dendritic Cells Results in Postintegration Inhibition of HIV-1 Replication.
Y. Bakri, C. Schiffer, V. Zennou, P. Charneau, E. Kahn, A. Benjouad, J. C. Gluckman, and B. Canque (2001)
J. Immunol. 166, 3780-3788
   Abstract »    Full Text »    PDF »
Strict Control of Human Immunodeficiency Virus Type 1 Replication by a Genetic Switch: Tet for Tat.
K. Verhoef, G. Marzio, W. Hillen, H. Bujard, and B. Berkhout (2001)
J. Virol. 75, 979-987
   Abstract »    Full Text »
In Vitro Induction of Human Immunodeficiency Virus Type 1 Variants Resistant to Phosphoralaninate Prodrugs of Z-Methylenecyclopropane Nucleoside Analogues.
K. Yoshimura, R. Feldman, E. Kodama, M. F. Kavlick, Y.-L. Qiu, J. Zemlicka, and H. Mitsuya (1999)
Antimicrob. Agents Chemother. 43, 2479-2483
   Abstract »    Full Text »
Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-gamma Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1.
I. Segura, C. Delmelle-Wibaut, M. Janssens, Y. Cleuter, A. van den Broeke, R. Kettmann, and K. E. Willard-Gallo (1999)
J. Virol. 73, 5207-5213
   Abstract »    Full Text »
The Susceptibility to X4 and R5 Human Immunodeficiency Virus-1 Strains of Dendritic Cells Derived In Vitro From CD34+ Hematopoietic Progenitor Cells Is Primarily Determined by Their Maturation Stage.
B. Canque, Y. Bakri, S. Camus, M. Yagello, A. Benjouad, and J. C. Gluckman (1999)
Blood 93, 3866-3875
   Abstract »    Full Text »    PDF »
Dendritic Cells Route Human Immunodeficiency Virus to Lymph Nodes after Vaginal or Intravenous Administration to Mice.
C. Masurier, B. Salomon, N. Guettari, C. Pioche, F. Lachapelle, M. Guigon, and D. Klatzmann (1998)
J. Virol. 72, 7822-7829
   Abstract »    Full Text »    PDF »
Extensive Diversification of Human Immunodeficiency Virus Type 1 Subtype B Strains during Dual Infection of a Chimpanzee That Progressed to AIDS.
Q. Wei and P. N. Fultz (1998)
J. Virol. 72, 3005-3017
   Abstract »    Full Text »    PDF »
Infection of Macaca nemestrina by human immunodeficiency virus type-1.
M. Agy, L. Frumkin, L Corey, R. Coombs, S. Wolinsky, J Koehler, W. Morton, and M. Katze (1992)
Science 257, 103-106
   Abstract »    PDF »
Mikulas Popovic's Letter on The HIV-1/HTLV-IIIB/83 Isolate and the Pooling Experiment.
(1991)
Science 253, 730
   PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)